Imunon enters change of control severance agreements with CEO, CMO, and GC

Imunon, Inc.

CEO Lindborg gets 2.5x base salary plus target bonus severance; others get 1.5x.
COBRA coverage: 24 months for CEO, 18 months for CMO and GC.
All unvested equity awards fully accelerate upon qualifying termination in change-of-control window.
Effective May 1, 2026; trigger period is 4 months before to 1 year after a change of control.
Benefits require a release of claims; 1-year non-compete covenant applies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.